The improvement in EPS indicates a positive direction in reducing losses, which could be seen favorably by investors. However, the decrease in sales year-over-year might raise concerns about the company's growth trajectory and could potentially offset the positive impact of the EPS improvement. Given these mixed signals, the short-term impact on BMRA's stock price is likely to be neutral.